Targeting Mitochondria through the Use of Mitocans as Emerging Anticancer Agents

被引:8
|
作者
Macasoi, Ioana [1 ]
Mioc, Alexandra [1 ]
Mioc, Marius [1 ]
Racoviceanu, Roxana [1 ]
Soica, Irina [2 ]
Cheveresan, Adelina [3 ]
Dehelean, Cristina [1 ]
Dumitrascu, Victor [3 ]
机构
[1] Victor Babes Univ Med & Pharm, Fac Pharm, 2 Eftimie Murgu, Timisoara 300041, Romania
[2] Earlscliffe Sixth Form, 29 Shorncliffe Rd, Folkestone CT20 2NB, England
[3] Victor Babes Univ Med & Pharm, Fac Med, 2 Eftimie Murgu, Timisoara 300041, Romania
关键词
Mithocondria; cancer; mitocans; electron transport chain; hexokinase; pyruvate dehydrogenase kinase; lactate dehydrogenase; Bcl-2; PERMEABILITY TRANSITION PORE; CYTOCHROME-C RELEASE; SMALL-MOLECULE INHIBITOR; SQUAMOUS-CELL CARCINOMA; CANCER-ASSOCIATED FIBROBLASTS; ATP SYNTHASE INHIBITOR; VITAMIN-E SUCCINATE; COMPLEX-I ACTIVITY; BETULINIC ACID; RESPIRATORY-CHAIN;
D O I
10.2174/0929867326666190712150638
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mitochondria are key players with a multi-functional role in many vital cellular processes, such as energy metabolism, redox regulation, calcium homeostasis, Reactive Oxygen Species (ROS) as well as in cell signaling, survival and apoptosis. These functions are mainly regulated through important enzyme signaling cascades, which if altered may influence the outcome of cell viability and apoptosis. Therefore some of the key enzymes that are vital for these signaling pathways are emerging as important targets for new anticancer agent development. Mitocans are compounds aimed at targeting mitochondria in cancer cells by altering mitochondrial functions thus causing cell growth inhibition or apoptosis. This review summarizes the till present known classes of mitocans, their mechanism of action and potential therapeutic use in different forms of cancer.
引用
收藏
页码:5730 / 5757
页数:28
相关论文
共 50 条
  • [31] Targeting Glucose Metabolism An Emerging Concept for Anticancer Therapy
    Madhok, Brijesh M.
    Yeluri, Sashidhar
    Perry, Sarah L.
    Hughes, Thomas A.
    Jayne, David G.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (06): : 628 - 635
  • [32] PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
    Khan, Sajid
    He, Yonghan
    Zhang, Xuan
    Yuan, Yaxia
    Pu, Shaoyan
    Kong, Qingpeng
    Zheng, Guangrong
    Zhou, Daohong
    ONCOGENE, 2020, 39 (26) : 4909 - 4924
  • [33] PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
    Sajid Khan
    Yonghan He
    Xuan Zhang
    Yaxia Yuan
    Shaoyan Pu
    Qingpeng Kong
    Guangrong Zheng
    Daohong Zhou
    Oncogene, 2020, 39 : 4909 - 4924
  • [34] Identification of Mitochondria-Targeting Anticancer Compounds by an in Vitro Strategy
    Zhang, Xiang
    Zhang, Shuyue
    Zhu, Shaobin
    Chen, Sha
    Han, Jinyan
    Gao, Kaimin
    Zeng, Jin-zhang
    Yan, Xiaomei
    ANALYTICAL CHEMISTRY, 2014, 86 (11) : 5232 - 5237
  • [35] Mitochondria-Targeting Thermosensitive Initiator with Enhanced Anticancer Efficiency
    Peng, Mengyun
    Wang, Xiao-Qiang
    Zhang, Yu
    Li, Chu-Xin
    Zhang, Mingkang
    Cheng, Han
    Zhang, Xian-Zheng
    ACS APPLIED BIO MATERIALS, 2019, 2 (10): : 4656 - 4666
  • [36] Multifunctional Mitochondria-Targeting Nanosystems for Enhanced Anticancer Efficacy
    Hu, Tingting
    Qin, Zhou
    Shen, Chao
    Gong, Han-Lin
    He, Zhi-Yao
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2021, 9
  • [37] Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents
    Colomer, Ramon
    Sarrats, Ariadna
    Lupu, Ruth
    Puig, Teresa
    CURRENT DRUG TARGETS, 2017, 18 (02) : 147 - 159
  • [38] Silver carbene complexes: An emerging class of anticancer agents
    Kankala, Shravankumar
    Thota, Niranjan
    Bjorkling, Fredrik
    Taylor, Myles K.
    Vadde, Ravinder
    Balusu, Ramesh
    DRUG DEVELOPMENT RESEARCH, 2019, 80 (02) : 188 - 199
  • [39] Histone deacetylase inhibitors: Emerging anticancer therapeutic agents?
    Kristeleit, Rebecca
    Fong, Peter
    Aherne, G. Wynne
    de Bono, Johann
    CLINICAL LUNG CANCER, 2005, 7 : S19 - S30
  • [40] Emerging Role of Natural Topoisomerase Inhibitors as Anticancer agents
    Sahu, Sanjeev Kumar
    Vyas, Manish
    Prabhakar, Pranav Kumar
    MEDICINAL CHEMISTRY, 2025, 21 (03) : 195 - 210